Which Type of Transcutaneous Electrical Nerve Stimulation is More Effective in Myofascial Pain Syndrome?

NCT ID: NCT04645095

Last Updated: 2020-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-05

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this project is to compare the effects of conventional, burst and modulated TENS primarily on pain level, number of trigger points, pressure pain threshold, neck joint range of motion and disability in MAS treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Myofascial pain syndrome (MAS) is a regional pain syndrome characterized by trigger points detected by one or several muscle groups and reflected pain manifestation caused by palpation of these points. Transcutaneous electrical nerve stimulation (TENS) is a physical therapy modality that provides an analgesic effect by delivering a controlled low voltage electrical current to the nervous system through electrodes placed on the skin. Knowledge on how modulation parameters such as frequency, wave width and form alter TENS activity are limited.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndromes

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Myofascial Pain Syndromes Transcutaneous Electrical Nerve Stimulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional TENS

Frequency:80 Hz, duration:100 μs

Group Type ACTIVE_COMPARATOR

Transcutaneous electrical nerve stimulation

Intervention Type DEVICE

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Hot pack

Intervention Type DEVICE

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Burst TENS

Frequency:100 Hz, fr mod: 0, 200 µs, 2 Bps Hz

Group Type ACTIVE_COMPARATOR

Transcutaneous electrical nerve stimulation

Intervention Type DEVICE

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Hot pack

Intervention Type DEVICE

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Modulated TENS

Frequency:80 Hz, fr mod: 50%, Amplitude mode: 40%, duration: 200 µs

Group Type ACTIVE_COMPARATOR

Transcutaneous electrical nerve stimulation

Intervention Type DEVICE

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Hot pack

Intervention Type DEVICE

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcutaneous electrical nerve stimulation

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Intervention Type DEVICE

Hot pack

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TENS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a diagnosis of myofascial pain syndrome according to the criteria defined by Travell and Simons

Exclusion Criteria

* The onset of symptoms is less than 3 months
* Severe cervical disc hernia, radiculopathy or myelopathy
* Stage 3-4 cervical degeneration
* Tumoral, infectious, psychiatric, neurological, uncontrolled systemic disease
* Cardiac pacemaker
* Diagnosed with fibromyalgia syndrome
* Kyphoscoliosis
* Acute trauma history
* Having had previous brain or shoulder surgery
* Injections for MAS and / or physiotherapy programs in the last 3 months
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Birkan Sonel Tur

Professor; MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Birkan Sonel Tur, Prof.

Role: PRINCIPAL_INVESTIGATOR

Ankara University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birkan Sonel Tur

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10-427-16

Identifier Type: -

Identifier Source: org_study_id